Literature DB >> 14744876

Functional properties of natural human PAX6 and PAX6(5a) mutants.

Bharesh K Chauhan1, Ying Yang, Kveta Cveklová, Ales Cvekl.   

Abstract

PURPOSE: Pax6 is essential for development of the eye, brain, and pancreas. Two major products of PAX6 are specific DNA-binding proteins, PAX6 and PAX6(5a). PAX6(5a) contains a short insertion influencing its DNA-binding activity. Heterozygous mutations in PAX6 result in abnormal eye development implicating haploinsufficiency. Deletions of one PAX6 allele result in aniridia characterized by severe ocular phenotypes. Approximately 10% of PAX6 mutations encode missense mutations. These mutations usually cause less severe abnormalities than does aniridia. The moderate phenotypes raise the possibility that different ocular tissues are differently sensitive to specific mutations. To test this hypothesis, we probed functional properties of individual mutated Pax6 proteins in a variety of conditions.
METHODS: Mutations in PAX6 and PAX6(5a) were introduced by site-directed mutagenesis and tested by transfections in four cell lines using reporters containing three different Pax6 binding sites. Pax6 binding to DNA was studied by electrophoretic mobility shift assays.
RESULTS: Functional studies of PAX6 and PAX6(5a) and their eight natural missense (G18W, R26G, A33P, S43P, G64V, I87R, V126D and R128C) and two nonsense (R317X and S353X) disease-causing mutants revealed unexpected pleiotropic effects in gene regulation, not predicted by the PAX6-DNA crystal structure. Transactivation by PAX6 and PAX6(5a) was dependent on the location of mutation, type of DNA-binding site, and cellular environment.
CONCLUSIONS: This work provides evidence that activation by PAX6 and PAX6(5a) is modulated by specific cellular environments. It is likely that moderate phenotypes associated with PAX6 missense mutations originate from abnormal protein function in a restricted number of ocular cell types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744876      PMCID: PMC2080871          DOI: 10.1167/iovs.03-0968

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  39 in total

Review 1.  Getting your Pax straight: Pax proteins in development and disease.

Authors:  Neil Chi; Jonathan A Epstein
Journal:  Trends Genet       Date:  2002-01       Impact factor: 11.639

2.  Modulation of PAX6 homeodomain function by the paired domain.

Authors:  S Singh; C M Stellrecht; H K Tang; G F Saunders
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

3.  Pax-6 is essential for lens-specific expression of zeta-crystallin.

Authors:  J Richardson; A Cvekl; G Wistow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

4.  DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5).

Authors:  T Czerny; M Busslinger
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 5.  PAX-6 in development and evolution.

Authors:  P Callaerts; G Halder; W J Gehring
Journal:  Annu Rev Neurosci       Date:  1997       Impact factor: 12.449

6.  Ten novel mutations found in Aniridia.

Authors:  M T Wolf; B Lorenz; A Winterpacht; M Drechsler; V Schumacher; B Royer-Pokora; A Blankenagel; B Zabel; G Wildhardt
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

7.  PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.

Authors:  T Glaser; L Jepeal; J G Edwards; S R Young; J Favor; R L Maas
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

8.  PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans.

Authors:  S M Sisodiya; S L Free; K A Williamson; T N Mitchell; C Willis; J M Stevens; B E Kendall; S D Shorvon; I M Hanson; A T Moore; V van Heyningen
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

9.  National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology.

Authors:  D Morrison; D FitzPatrick; I Hanson; K Williamson; V van Heyningen; B Fleck; I Jones; J Chalmers; H Campbell
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

Review 10.  PAX6 mutations reviewed.

Authors:  J Prosser; V van Heyningen
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

View more
  24 in total

1.  The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops.

Authors:  Qing Xie; Ales Cvekl
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

2.  Functional dissection of the paired domain of Pax6 reveals molecular mechanisms of coordinating neurogenesis and proliferation.

Authors:  Tessa Walcher; Qing Xie; Jian Sun; Martin Irmler; Johannes Beckers; Timucin Öztürk; Dierk Niessing; Anastassia Stoykova; Ales Cvekl; Jovica Ninkovic; Magdalena Götz
Journal:  Development       Date:  2013-03       Impact factor: 6.868

3.  Pax6 localizes to chromatin-rich territories and displays a slow nuclear mobility altered by disease mutations.

Authors:  Julianne Elvenes; Eva Sjøttem; Turid Holm; Geir Bjørkøy; Terje Johansen
Journal:  Cell Mol Life Sci       Date:  2010-06-25       Impact factor: 9.261

4.  The Long Noncoding RNA Paupar Modulates PAX6 Regulatory Activities to Promote Alpha Cell Development and Function.

Authors:  Ruth A Singer; Luis Arnes; Yi Cui; Jiguang Wang; Yuqian Gao; Michelle A Guney; Kristin E Burnum-Johnson; Raul Rabadan; Charles Ansong; Galya Orr; Lori Sussel
Journal:  Cell Metab       Date:  2019-10-10       Impact factor: 27.287

5.  Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter.

Authors:  Ying Yang; Ales Cvekl
Journal:  J Mol Biol       Date:  2005-08-19       Impact factor: 5.469

Review 6.  Regulation of gene expression by Pax6 in ocular cells: a case of tissue-preferred expression of crystallins in lens.

Authors:  Ales Cvekl; Ying Yang; Bharesh K Chauhan; Kveta Cveklova
Journal:  Int J Dev Biol       Date:  2004       Impact factor: 2.203

7.  Pax6 regulation of Math5 during mouse retinal neurogenesis.

Authors:  Amy N Riesenberg; Tien T Le; Minde I Willardsen; David C Blackburn; Monica L Vetter; Nadean L Brown
Journal:  Genesis       Date:  2009-03       Impact factor: 2.487

Review 8.  Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases.

Authors:  Ales Cvekl; Ernst R Tamm
Journal:  Bioessays       Date:  2004-04       Impact factor: 4.345

9.  PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene.

Authors:  Joseph B Mascarenhas; Kacey P Young; Erica L Littlejohn; Brian K Yoo; Ravi Salgia; Deborah Lang
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

10.  Functional interactions between alternatively spliced forms of Pax6 in crystallin gene regulation and in haploinsufficiency.

Authors:  Bharesh K Chauhan; Ying Yang; Kveta Cveklová; Ales Cvekl
Journal:  Nucleic Acids Res       Date:  2004-03-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.